This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jw Pharmaceutical Corporation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Mi-Jung Kim: Innovator in Cancer Treatment
Introduction
Mi-Jung Kim is a prominent inventor based in Suwon-si, South Korea. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can aid in the treatment of serious diseases such as cancer.
Latest Patents
Mi-Jung Kim holds a patent for a "Compound of a reverse-turn mimetic and a production method and use therefor." This invention relates to novel compounds of reverse-turn mimetics, having pyrazino-triazinone as a basic framework. The method of preparing these compounds and their use in treating diseases, especially acute myeloid leukemia, showcases her innovative approach to addressing critical health challenges. She has 1 patent to her name.
Career Highlights
Mi-Jung Kim is currently associated with Jw Pharmaceutical Corporation, where she continues to work on groundbreaking research and development projects. Her role at the company allows her to collaborate with other talented professionals in the field.
Collaborations
Some of her notable coworkers include Jae-Uk Chung and Yong-Sil Lee, who contribute to her research endeavors and help advance the company's mission in pharmaceutical innovation.
Conclusion
Mi-Jung Kim's work exemplifies the vital role of inventors in the fight against cancer. Her innovative compounds and dedication to research are paving the way for new treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile